MDNA
Medicenna Therapeutics Corp. Common Shares
MDNA
MDNA
Delisted
MDNA was delisted on the 1st of November, 2023.
19 hedge funds and large institutions have $5.41M invested in Medicenna Therapeutics Corp. Common Shares in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$230K | |
| 2 | +$60K | |
| 3 | +$30.9K | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$29.2K |
| 5 |
GVAG
Great Valley Advisor Group
Wilmington,
Delaware
|
+$23K |
Top Sellers
| 1 | -$117K | |
| 2 | -$26K | |
| 3 | -$8.76K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.33K |
| 5 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$3.98K |